Merck & Co has been fighting to defend its blockbuster type 2 diabetes therapy Januvia from generic competition for years, and a new judgment looks set to protect its third biggest-selling drug ...
Hosted on MSN1mon
Merck Falls 9% in 3 Months: Buy, Hold or Sell the Stock?Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck faces broader industry pressure as vaccine skeptic Robert F. Kennedy Jr. possibly next ...
This is attributed to declining sales of its blockbuster HPV vaccine – Gardasil – and an increased competition for some of its drugs, including Januvia. As an aside, new gaming products can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback